Darren R. Sherman's most recent trade in Orchestra BioMed Holdings Inc was a trade of 40,340 Common Stock, par value $0.0001 per share done at an average price of $2.7 . Disclosure was reported to the exchange on Sept. 3, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Orchestra BioMed Holdings Inc | Darren R. Sherman | Director, See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.72 per share. | 03 Sep 2025 | 40,340 | 886,497 | - | 2.7 | 109,725 | Common Stock, par value $0.0001 per share |
| Orchestra BioMed Holdings Inc | Darren R. Sherman | Director, See Remarks | Purchase of securities on an exchange or from another person at price $ 2.62 per share. | 25 Aug 2025 | 3,000 | 926,837 | - | 2.6 | 7,860 | Common Stock, par value $0.0001 per share |
| Orchestra BioMed Holdings Inc | Darren R. Sherman | Director, See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Aug 2025 | 120,000 | 923,837 | - | 0 | Common Stock, par value $0.0001 per share ("Common Stock") | |
| Orchestra BioMed Holdings Inc | Darren R. Sherman | Director, See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.95 per share. | 28 May 2025 | 45,843 | 803,837 | - | 3.0 | 135,237 | Common Stock, par value $0.0001 per share ("Common Stock") |
| Orchestra BioMed Holdings Inc | Darren R. Sherman | Director, See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Apr 2025 | 115,708 | 849,680 | - | 0 | Common Stock, par value $0.0001 per share ("Common Stock") |